Bank of America lowers Moderna (NASDAQ:MRNA) price target from $175 to $150

By / / Bank of America, Moderna

Bank of America Securities analyst Geoff Meacham maintains Moderna (NASDAQ:MRNA) with a Neutral and lowers the price target from $175 to $150.

Scroll to Top